methoxyhydroxyphenylglycol has been researched along with selegiline in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (50.00) | 18.7374 |
| 1990's | 8 (40.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuhn, W; Przuntek, H | 1 |
| Blandini, F; Bono, G; Martignoni, E; Merlo, P; Nappi, G; Sinforiani, E | 1 |
| Cohen, RM; Mellow, AM; Mueller, EA; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN | 1 |
| Kaarttinen, A; Kallio, J; Koulu, M; Pyykkö, K; Scheinin, M; Vuorinen, J; Zimmer, RH | 1 |
| Kraus, P; Kuhn, W; Przuntek, H | 1 |
| Goldstein, DS; Hovevey-Sion, D; Kopin, IJ; Stull, RW | 1 |
| Eisenhofer, G; Goldstein, DS; Keiser, HR; Kopin, IJ; Murphy, DL; Stull, R; Sunderland, T | 1 |
| Gibson, CJ | 1 |
| Glover, V; Goodwin, BL; Prasad, A; Sandler, M; Signy, M; Smith, SE | 1 |
| Davies, SO; Karoum, F; Levitt, M; Liebowitz, MR; Linnoila, M; Quitkin, FM; Schwartz, D | 1 |
| Cohen, RM; Jimerson, DC; Mueller, EA; Murphy, DL; Pickar, D; Sunderland, T | 1 |
| Calne, DB; Ebert, MH; Eisler, T; Kopin, IJ; Krebs, H; Lake, CR; Murphy, DL; Nelson, R; Teräväinen, H; Weise, V; Whetzel, N | 1 |
| Cohen, RM; Lawlor, BA; Mellow, AM; Molchan, S; Mueller, EA; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN | 1 |
| Ahlskog, JE; Low, PA; Nickander, KK; O'Brien, JF; Tyce, GM; Uitti, RJ | 1 |
| Dingemanse, J; Kettler, R; Kneer, J; Korn, A; Koulu, M; Wallnöfer, A; Zürcher, G | 1 |
| Illi, A; Koulu, M; Ojala-Karlsson, P; Scheinin, M | 1 |
| Berlin, F; Breakefield, XO; Eisenhofer, G; Ernst, M; George, T; Greenberg, BD; Murphy, DL; Sims, K; Zametkin, A | 1 |
| Caramona, M; Figueiredo, IV; Guimarães, S; Paiva, MQ | 1 |
| Everhart, T; Harris, DS; Jacob, P; Jones, RT; Lin, E; Mendelson, JE | 1 |
| Adar, L; Goren, T; Sasson, N; Weiss, YM | 1 |
9 trial(s) available for methoxyhydroxyphenylglycol and selegiline
| Article | Year |
|---|---|
Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl.
Topics: Aged; Alzheimer Disease; Biogenic Monoamines; Cognition; Dopamine; Double-Blind Method; Epinephrine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Norepinephrine; Psychiatric Status Rating Scales; Psychological Tests; Selegiline | 1991 |
Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Blood Platelets; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Epinephrine; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Pituitary Hormones, Anterior; Random Allocation; Selegiline; Vanilmandelic Acid | 1989 |
Biochemical effects of L-deprenyl in atypical depressives.
Topics: Adult; Clinical Trials as Topic; Depressive Disorder; Dextroamphetamine; Dose-Response Relationship, Drug; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Phenethylamines; Selegiline | 1985 |
Tyramine pressor sensitivity changes during deprenyl treatment.
Topics: Blood Pressure; Dose-Response Relationship, Drug; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Phenethylamines; Selegiline; Tyramine | 1985 |
Deprenyl in Parkinson disease.
Topics: Adult; Aged; Carbidopa; Dopamine; Double-Blind Method; Drug Combinations; Epinephrine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Phenethylamines; Selegiline | 1981 |
High-dose selegiline in treatment-resistant older depressive patients.
Topics: Age Factors; Aged; Blood Pressure; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxyindoleacetic Acid; Hypotension, Orthostatic; Male; Methoxyhydroxyphenylglycol; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selegiline; Treatment Outcome | 1994 |
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Blood Platelets; Double-Blind Method; Drug Interactions; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Selegiline | 1996 |
A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.
Topics: Administration, Cutaneous; Adult; Affect; Amphetamine; Amphetamines; Analysis of Variance; Cocaine; Dopamine Uptake Inhibitors; Drug Interactions; Female; Homovanillic Acid; Humans; Infusions, Intravenous; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Monitoring, Physiologic; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenethylamines; Prolactin; Selegiline; Statistics, Nonparametric; Substance Withdrawal Syndrome; Young Adult | 2009 |
Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline.
Topics: Adult; Aged; Algorithms; Contraindications; Diet; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Humans; Hypertension; Indans; Isoenzymes; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Tyramine; United States | 2010 |
11 other study(ies) available for methoxyhydroxyphenylglycol and selegiline
| Article | Year |
|---|---|
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPS, HIAA, and HVA levels of cerebrospinal fluid.
Topics: Carboxy-Lyases; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Selegiline | 1990 |
Dose-dependent effects of deprenyl on CSF monoamine metabolites in patients with Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Biogenic Amines; Dose-Response Relationship, Drug; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Phenethylamines; Selegiline | 1987 |
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid.
Topics: Benserazide; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Glycols; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Activity; Parkinson Disease; Phenethylamines; Selegiline | 1989 |
Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechols; Clorgyline; Corpus Striatum; Debrisoquin; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Nialamide; Norepinephrine; Rats; Rats, Inbred Strains; Selegiline | 1989 |
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Topics: Alzheimer Disease; Animals; Catecholamines; Chromatography, Liquid; Depression; Dihydroxyphenylalanine; Dogs; Glycols; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Posture; Quality Control; Selegiline; Tranylcypromine | 1986 |
Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons.
Topics: Animals; Benzylamines; Brain Chemistry; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Mice; Monoamine Oxidase Inhibitors; Neurotoxins; Norepinephrine; Pargyline; Selegiline | 1987 |
Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment.
Topics: Adult; Blood Platelets; Blood Pressure; Female; Humans; Male; Methoxyhydroxyphenylglycol; Phenethylamines; Pulse; Selegiline; Tyramine | 1988 |
Levodopa and deprenyl treatment effects on peripheral indices of oxidant stress in Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Aged, 80 and over; Cysteinyldopa; Humans; Levodopa; Malondialdehyde; Methoxyhydroxyphenylglycol; Middle Aged; Oxidative Stress; Parkinson Disease; Selegiline | 1996 |
Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase.
Topics: Antiparkinson Agents; Benzamides; Biomarkers; Catechol O-Methyltransferase Inhibitors; Catechols; Chromatography, High Pressure Liquid; Humans; Male; Methoxyhydroxyphenylglycol; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nitriles; Norepinephrine; Pentanones; Selegiline | 1998 |
Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
Topics: Adolescent; Adult; Aged; Animals; Attention Deficit Disorder with Hyperactivity; Chromosome Deletion; Chromosome Mapping; Domestic Violence; Humans; Isoenzymes; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Reference Values; Risk Assessment; Selegiline; Sex Offenses; X Chromosome | 1998 |
The role of MAO-A and MAO-B in the metabolic degradation of noradrenaline in human arteries.
Topics: Aged; Arteries; Clorgyline; Humans; Mandelic Acids; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Selegiline | 1998 |